• In early June 2026, Planet Labs PBC reported first-quarter revenue of US$94.15 million versus US$66.27 million a year earlier, alongside a net loss of US$138.87 million and filed a new shelf registration for an at-the-market follow-on equity offering of up to US$1.50 billion in Class A common stock.
• At the same time, Planet advanced its Pelican satellite roadmap with the Pelican-11 tech demonstrator and issued stronger revenue guidance, highlighting a business balancing heavy investment, capital-raising needs, and growing demand for its higher-resolution Earth observation data.
• We’ll now examine how Planet’s US$1.50 billion at-the-market equity program may reshape its pre-existing investment narrative around growth and dilution.

Find 47 companies with promising cash flow potential yet trading below their fair value.

Planet Labs PBC Investment Narrative Recap

To own Planet Labs today, you need to believe its growing demand for high cadence, AI-ready Earth imagery will ultimately outweigh persistent losses and heavy capital needs. The new US$1.50 billion at-the-market program brings that trade off into focus by increasing the importance of equity dilution as the key near term risk, even as execution on Pelican launches and large, multi year contracts remains the main positive catalyst.

The Pelican 11 tech demonstrator is especially relevant here. It underscores that Planet is still in an investment heavy phase, pushing toward higher resolution (30 cm class) data that can support higher value solutions. That kind of product roadmap helps explain why management would want flexible access to new capital, but it also tightens the link between successful deployment of Pelican capacity and how investors judge the impact of future share issuance.

Yet beneath the growth story, investors should be aware that dilution risk from the US$1.50 billion program could...

Planet Labs PBC's narrative projects $744.3 million revenue and $54.6 million earnings by 2029. This requires 34.2% yearly revenue growth and a $301.5 million earnings increase from -$246.9 million today.

Uncover how Planet Labs PBC's forecasts yield a $36.33 fair value, a 11% upside to its current price.

Exploring Other Perspectives

Against that backdrop, the most bearish analysts were already assuming only about 17 percent annual revenue growth to roughly US$400 million and no profits by 2028, so this new equity plan may reinforce their concern that high costs and potential dilution could weigh on the story longer than consensus expects.

Explore 11 other fair value estimates on Planet Labs PBC - why the stock might be worth as much as 53% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Planet Labs PBC research is our analysis highlighting 1 key reward and 4 important warning signs that could impact your investment decision.
• Our free Planet Labs PBC research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Planet Labs PBC's overall financial health at a glance.

Want Some Alternatives?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Explore 30 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 13 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.